SCHEMBL25600424

SCHEMBL25600424

CCC1(CC)c2cc(OC)ccc2-c2c1c1c(c3cc(OC)ccc23)OC(c2ccc(OC)cc2)(c2ccc(N3CCOCC3)cc2)C=C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.36
ADAM17 P78536 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
AKR1C3 P42330 1/20 0.33
MAPT P10636 5/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HTT P42858 1/20 0.32
LRRK2 Q5S007 1/20 0.32
PRKDC P78527 7/20 0.32
APP P05067 1/20 0.31
CYP1A2 P05177 1/20 0.31
HPGD P15428 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25600425 0.99 ADAM17 (0.36) RAB9AADAM17L3MBTL1AKR1C3MAPT
SCHEMBL25844714 0.95 RAB9A (0.34) RAB9AADAM17L3MBTL1AKR1C3MAPT
SCHEMBL25844717 0.95 ADAM17 (0.34) RAB9AADAM17L3MBTL1AKR1C3MAPT
SCHEMBL27277553 0.94 RAB9A (0.35) RAB9AADAM17L3MBTL1AKR1C3MAPT
SCHEMBL25600300 0.94 RAB9A (0.35) RAB9AADAM17L3MBTL1AKR1C3MAPT
SCHEMBL25607034 0.93 ADAM17 (0.33) RAB9AADAM17L3MBTL1AKR1C3MAPT
SCHEMBL25844668 0.93 ADAM17 (0.35) RAB9AADAM17L3MBTL1MAPTPOLB
SCHEMBL25665511 0.93 ALK (0.38) RAB9AADAM17L3MBTL1MAPTPOLB
SCHEMBL25600545 0.93 PRKDC (0.35) RAB9AADAM17MAPTTSHRMAPK1
SCHEMBL25718166 0.93 ADAM17 (0.33) RAB9AADAM17L3MBTL1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
EP-4198102-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 RAB9A 1795/4885ADAM17 4791/4885L3MBTL1 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.